MedPath

The effect of Pomegranate supplement on Ulcerative Colit

Phase 3
Recruiting
Conditions
lcerative Colit.
Registration Number
IRCT20200614047774N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

Disease diagnosed by a Gastroenterologist
The patient's medical condition has been stable for the past two months
The desire to participate in the study

Exclusion Criteria

Sensitivity to pomegranate or its products
Pregnancy
Lactation
Taking steroid drugs, other experimental drugs, and probiotics
Kidney, heart and hepatitis
Taking other nutritional supplements
Having a special diet

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IL-6. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;IL-10. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;TNF-alpha. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;Hs-CRP. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;ANCA. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;Fecal Calprotectin. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.
Secondary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: The beginning and end of the study. Method of measurement: IBDQ-9 questionaire.;Severity of symptoms. Timepoint: The beginning and end of the study. Method of measurement: SCCAI questionair.;Antropometric Index. Timepoint: The beginning and end of the study. Method of measurement: Body measurement.
© Copyright 2025. All Rights Reserved by MedPath